Literature DB >> 6362558

Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.

M E Gombert, T M Aulicino.   

Abstract

The in vitro activities of imipenem (formerly imipemide, N-formimidoyl thienamycin, or MK0787) and amikacin in combination with cefotaxime, trimethoprim-sulfamethoxazole, and each other were tested against 26 Nocardia asteroides strains. The agar dilution method was used for all tests. Synergy was present in 80% of tests with imipenem-trimethoprim-sulfamethoxazole, in 92% of tests with imipenem-cefotaxime, and in 83% of tests with amikacin-trimethoprim-sulfamethoxazole. Indifference was found on rare occasions, and no antagonism was seen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362558      PMCID: PMC185947          DOI: 10.1128/AAC.24.5.810

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Nocardia asteroides; studies of its pathogenicity and drug sensitivities.

Authors:  E H RUNYON
Journal:  J Lab Clin Med       Date:  1951-05

2.  Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice.

Authors:  M C Bach; O Gold; M Finland
Journal:  J Lab Clin Med       Date:  1973-05

3.  Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin.

Authors:  M C Bach; A P Monaco; M Finland
Journal:  JAMA       Date:  1973-06-04       Impact factor: 56.272

4.  In vitro studies of the combined effect of ampicillin and sulfonamides on Nocardia asteroides and results of therapy in four patients.

Authors:  M G Orfanakis; H G Wilcox; C B Smith
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

5.  Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.

Authors:  M E Gombert
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

6.  Trimethoprim-sulfamethoxazole therapy for Nocardia infections.

Authors:  R A Smego; M B Moeller; H A Gallis
Journal:  Arch Intern Med       Date:  1983-04
  6 in total
  15 in total

1.  A fatal case of pulmonary nocardiosis.

Authors:  Mahantesh Patil; Shivaprasad C; Jaicob Varghese; Natarajan Rajagopalan
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  Brain and lung lesions in an immunocompromised man.

Authors:  Jerome A Leis; Paul E Bunce; Todd C Lee; Wayne L Gold
Journal:  CMAJ       Date:  2010-09-27       Impact factor: 8.262

3.  Susceptibility of Nocardia asteroides to new quinolones and beta-lactams.

Authors:  M E Gombert; T M Aulicino; L duBouchet; L R Berkowitz
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  Disseminated nocardiosis with multisite involvement in an immunocompetent patient.

Authors:  Arjun Balachandar; Alice Zhabokritsky; Larissa M Matukas
Journal:  CMAJ       Date:  2020-08-17       Impact factor: 8.262

Review 5.  Nocardiosis: updates and clinical overview.

Authors:  John W Wilson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

6.  Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline.

Authors:  M E Gombert; T M Aulicino; L duBouchet; G E Silverman; W M Sheinbaum
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

Review 7.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

8.  Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica.

Authors:  R J Wallace; M Tsukamura; B A Brown; J Brown; V A Steingrube; Y S Zhang; D R Nash
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Nocardia cyriacigeorgica, an emerging pathogen in the United States.

Authors:  Robert Schlaberg; Richard C Huard; Phyllis Della-Latta
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

Review 10.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.